Coronavirus Latest: NIH-Funded Clinical Trial For COVID-19 Vaccine Begins Monday

WASHINGTON (WJZ) -- A clinical trial begins Monday in Seattle, Washington to evaluate a vaccine designed to protect against the new coronavirus.

The National Institute of Health in Washington D.C. is funding the trial.

The first participant in the trial will receive the experimental vaccine Monday.

Public health officials said it will take a year to 18-months to see if the vaccine works and make it available to the public.

For the latest information on coronavirus go to the Maryland Health Department's website or call 211. You can find all of WJZ's coverage on coronavirus in Maryland here.

In:
• COVID-19
• DC
• Washington